BA
NUVL

Bridgewater Associates’s Nuvalent NUVL Stock Holding History

Bridgewater Associates’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Sell
15,020
-3,558
-19% -$363K 0.01% 709
2025
Q4 		$1.87M Sell
18,578
-3,479
-16% -$343K 0.01% 781
2025
Q3 		$1.91M Buy
+22,057
New +$1.74M 0.01% 737

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bridgewater Associates's NUVL Position: Q1 2026 in Review

Bridgewater Associates reduced its Nuvalent (NUVL) stake by 19% in Q1 2026, selling an estimated $363K and leaving 15,020 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #709.

Bridgewater Associates first reported a position in NUVL in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.91M in Q3 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Bridgewater Associates held 15,020 shares of Nuvalent worth $1.54M as of Q1 2026.
  • Bridgewater Associates sold 3,558 Nuvalent shares in Q1 2026, an estimated $363K.
  • Nuvalent made up 0.01% of Bridgewater Associates's portfolio in Q1 2026, its #709 holding.
  • Bridgewater Associates first reported a position in Nuvalent in Q3 2025 and has held it in 3 quarters since.
  • Bridgewater Associates's Nuvalent position peaked at $1.91M in Q3 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.